Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 56Stomach Neoplasms 27Pancreatic Neoplasms 18Rectal Neoplasms 16Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Neoplasm Metastasis 11Esophageal Squamous Cell Carcinoma 8Esophageal Neoplasms 8Colonic Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Carcinoma, Hepatocellular 8Adenocarcinoma 8Head and Neck Neoplasms 7Gastrointestinal Neoplasms 7Biliary Tract Neoplasms 6Adenocarcinoma Of Esophagus 6Ovarian Neoplasms 5Peritoneal Neoplasms 4Advanced Solid Tumors 4Urinary Bladder Neoplasms 3Nasopharyngeal Carcinoma 3Lung Neoplasms 3Endometrial Neoplasms 3Cholangiocarcinoma 3Carcinoma, Transitional Cell 3Carcinoma 3Breast Neoplasms 3Appendiceal Neoplasms 3Locally Recurrent Rectal Cancer 2

Interventions

dolutegravir 1Tenofovir 1Oxaliplatin 1Leucovorin 1Ketotifen 1Fluorouracil 1Bestrophins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Neuritis × Fluorouracil × Clear all
NCT05624138 2025-05-11

The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy

Tanta University

Phase 3 Recruiting
64 enrolled

Neuritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡